Clinical trial
Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy
NCT00153517 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00153517 |
|---|---|
| Title | Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy |
| Official title | Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy (Randomized Trial of BV Treatment in Pregnancy) |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Vaginosis, Bacterial, Premature Birth, Birth Weight, Chorioamnionitis |
| Intervention type | Drug |
| Interventions | oral versus vaginal metronidazole |
| Enrollment | 126 |
| Start date | Oct 1, 1999 |
| Primary completion | Sep 1, 2004 |
| Completion | Sep 1, 2004 |
| First posted | Sep 12, 2005 |
| Last update posted | May 29, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: